Global Stem Cell and Advanced Technologies Market
Global Stem Cell and Advanced Technologies Market
By: marketsandmarkets.com
Publishing Date:November 2009
Report Code: BT 1034
Report Description
The stem cell market is growing rapidly due to increasing regulatory approval. The benefits of the stem cell therapy are also attracting an increasing number of patients. Intensive R&D efforts and the increasing research investments on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. The product submarkets for human and embryo stem cells are also expected to drive the growth of the overall stem cells market. However, the high cost of the therapy may affect market growth. This report will help stakeholders gain a better understanding of product pricing and regulatory framework governing market dynamics. The U.S. currently forms the most lucrative stem cells market, especially for areas such as stem cell bone marrow transplantation.
Scope of the report
The report categorizes the global stem cell market as follows:
- Products (adult stem cell, human embryonic stem cell, and other stem cell types)
- Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
- Technology (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
- Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)
What makes our reports unique?
- We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
- We provide 10% customization to ensure that our clients find the specific market intelligence they need.
- Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
- No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
- 15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.
Key questions answered
- Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what factors are driving market growth?
- Which are the key playing fields and winning-edge imperatives?
- What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.
Table of contents
Executive summary
MARKET OVERVIEW
Stem cell market dynamics
OPPORTUNITIES
Stem cells product market
OPPORTUNITIES
Stem cells technology market
Stem cells services market
Stem cells applications market
Geographic analysis
Competitive landscape
1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. REPORT DESCRIPTION
1.3. Research METHODOLOGY
1.4. STAKEHOLDERS
2. Summary
3. market overview
3.1. Defining the stem cell market
3.2. Factors influencing the stem cells market
3.3. Stem cell market inhibitors
3.4. Regenerative medicine dominates stem cell applications
3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
3.5.1. U.S. Liberal Politics
3.5.2. Guidelines for responsible stem cells research
3.5.3. European national policies and legal issues
3.5.4. E.U. funding for stem cells research
3.5.5. Asia Pacific
3.6. Stem cell patent analysis
4. Stem cell market dynamics
4.1. Drivers
4.1.1. Potential of stem cells in regenerative medicine
4.1.2. Key to anti-ageing and prolonging life
4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
4.1.4. EASE of administration
4.1.5. Reduced risk of tissue rejection in transplants
4.1.6. Federal funding for stem cell research
4.2. Restraints
4.2.1. safety issues
4.2.2. Ethical issueS
4.2.3. minimal Insurance coverage
4.3. Opportunities
4.3.1. technological innovations
4.3.2. Emerging application as a drug discovery tool
4.3.3. other promising applications
5. Global stem cells product market
5.1. Stem cell classification on the basis of potency
5.2. Adult stem cells
5.2.1. Drivers
5.2.1.1. Applications in cancer and chronic disease treatment
5.2.1.2. Availability of adequate safety & efficacy evidence
5.2.1.3. Technology innovations
5.2.1.4. Lower costs & no ethical issues
5.2.2. Restraints & Opportunities
5.2.2.1. Lower therapeutic potential
5.2.2.2. Need for minimising intervention
5.2.3. Hematopoietic Stem Cells
5.2.3.1. Drivers & Restraints
5.2.3.1.1. Wide range of applications
5.2.3.1.2. Enhanced usage due to recent technology advancements
5.2.3.1.3. Underused treatment, ineffective GvHD management
5.2.4. Mesenchymal stem cells
5.2.4.1. Drivers
5.2.4.1.1. Huge potential of MSCs
5.2.4.1.2. Advantageous cell type for allogenic transplantation
5.2.4.2. Restraints & Opportunities
5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
5.2.4.3. Potential applications of MSC therapy
5.3. Embryonic stem cells
5.3.1. Drivers & REStraints
5.3.1.1. Immense potential due to pluripotent nature
5.3.1.2. Ban on federal funding lifted
5.3.1.3. Ethical issues and inadequate safety data
5.3.2. Umbilical cord stem cells
5.3.3. Neuronal stem cells
5.3.4. Dental stem cells
5.3.5. Other novel cell types
6. stem cells technology market
6.1. Stem cell production
6.1.1. Somatic nuclear transfer / Therapeutic cloning
6.1.2. IVF (In vitro fertilization)
6.1.3. Isolation & Cell culture
6.2. Expansion & Sub culture
6.3. Stem cell acquisition
6.3.1. Bone marrow harvest
6.3.2. Apheresis
6.3.3. Umbilical cord blood stem cells acquisition
6.4. Cryopreservation & storage
7. Global stem cells services market
7.1. Stem cell banking
7.1.1. Ethical issues on stem cell banking
7.2. Stem cell acquisition & testing
7.3. Characterization services
7.3.1. HLA typing services
7.3.2. Stem cell custom services
7.3.3. Stem cell custom antibody services
7.4. Molecular biology
7.5. Drug screening & target validation
8. Global stem cells applications market
8.1. Regenerative medicine
8.1.1. Drivers & Restraints
8.1.1.1. Simple and cost-effective production method
8.1.1.2. Public & political support
8.1.1.3. High cost of treatment and low reimbursements
8.1.2. Neurological disorders
8.1.2.1. Alzheimer’s disease
8.1.2.2. Parkinson’s disease
8.1.2.3. Multiple sclerosis
8.1.2.4. Others
8.1.3. Myocardial Infarction & cardiovascular diseases
8.1.4. Cancer
8.1.4.1. Breast cancer
8.1.4.2. Multiple myeloma
8.1.4.3. Other diseases
8.1.5. Injuries
8.1.6. Incontinence
8.1.7. Diabetes
8.1.8. Orthopedics
8.1.9. Liver disorders
8.1.10. Hematological disorders
8.1.10.1. Other applications
8.1.10.1.1. Limb Ischemia
8.1.10.1.2. Systemic lupus
8.2. Drug Discovery & Development
9. Geographic analysis
9.1. North America
9.2. Europe
9.3. Asia
9.4. ROW
10. Competitive landscape
Appendix
10.1. Government policies & guidelines
10.1.1. Patents for united states
10.1.2. Patents for europe
10.1.3. Patents for Japan
11. Company Profiles
11.1. Advanced Cell Technology Inc
11.2. Aldagen
11.3. Angel Biotechnology
11.4. Angioblast Systems Inc
11.5. Aastrom Biosciences Inc
11.6. Athersys
11.7. Bioheart Inc
11.8. Brainstorm Cell Therapeutics
11.9. California Stem Cell
11.10. Celgene Corporation
11.11. Cellartis AB
11.12. Cellerant Therapeutics
11.13. Cellular Dynamics International, Inc
11.14. Cellular Engineering Technologies
11.15. CordLife Ltd
11.16. Cytori Therapeutics Inc
11.17. ES Cell International
11.18. Gamida Cell Ltd
11.19. Genzyme Corporation
11.20. Geron Corporation Inc
11.21. Global Stem Inc
11.22. Intercytex (and its subsidiary Axordia)
11.23. Medistem Inc
11.24. Mesoblast Ltd
11.25. MultiCell Technologies, Inc
11.26. Neostem
11.27. Novocell Inc
11.28. NeuralStem Biopharmaceuticals, Ltd.
11.29. Opexa Therapeutics
11.30. Osiris Therapeutics, Inc
11.31. Plureon Corp
11.32. Pluristem Therapeutics
11.33. ReNeuron, Inc
11.34. StemCells, Inc
11.35. StemLifeLine
11.36. t2cure Gmbh
11.37. TheraVitae
11.38. Thermo Fisher Scientific Inc
11.39. Thermogenesis Corporation
11.40. VetCell Bioscience Ltd
List of TableS
SUMMARY TABLE Global stem cell market 2009-2014 ($ thousands)
Table 1 Global stem cell market by product 2007-2014 ($ Millions)
Table 2 Global adult stem cell market by product 2007-2014 ($ Millions)
Table 3 Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4 Global stem cell technology market 2007-2014 ($ Millions)
Table 5 Global stem cell production market by product 2007-2014 ($ Millions)
Table 6 Global stem cell acquisition market by product 2007-2014 ($ Millions)
Table 7 Global stem cell services market by product 2007-2014 $ Millions)
Table 8 Global characterization services market by product 2007-2014 ($ Millions)
Table 9 Global stem cell applications market by product 2007-2014 ($ Thousands)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions)
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions)
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions)
Table 13 Global neurological disorders market by geography 2007-2014 ($ Millions)
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions)
Table 15 Global cancer market by geography 2007-2014 ($ Millions)
Table 16 Global Injuries market for stem cells by product 2007-2014 ($ Millions)
Table 17 Global Injuries market for stem cells by geography 2007-2014 ($ Millions)
Table 18 Global Incontinence market for stem cells by geography 2007-2014 ($ Millions)
Table 19 Global Diabetes market by geography 2007-2014 ($ Millions)
Table 20 Global Orthopedics market in stem cells by geography 2007-2014 ($ Millions)
Table 21 Global Liver disorders market by geography 2007-2014 ($ Millions)
Table 22 Global Hematological disorders market by geography 2007-2014 ($ Millions)
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions)
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions)
Table 28 New product, technology, service launch (2008-2009)
Table 29 List of agreements and collaborations (2008-2009)
Table 30 List of mergers and acquisition (2008-2009)
List of FIGURES
Figure 1 STEM CELL MARKET SEGMENTATION
Figure 2 Driving factors
Figure 3 Inhibitor matrix
Figure 4 Stem cell application market dynamics
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
Figure 6 NIH funding for stem cell research
Figure 7 patent analysis by geography 2006 to 2008
Figure 8 Patent analysis by segment 2006 to 2008
Figure 9 Patent analysis by competitors
Figure 10 Major market growth factors
Figure 11 Stem cell classification on the basis of potency
Figure 12 Stem cell technologies
Figure 13 Prominent focus areas in regenerative medicine
Figure 14 Stem cell transplants types
Figure 15 global Stem cells market by geography ($billion)
Figure 16 North American Stem cells market
Figure 17 european Stem cells market
Figure 18 asian Stem cells market
Figure 19 row Stem cells market
Figure 20 Major segments focused by global stem cell market players (2008-2009)
figure 21 Competitive landscape for collaborations (2008-2009)
Global Stem Cell and Advanced Technologies Market
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.
The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.
Estimated size of stem cell market in 2009
